Webpackaging logo

Interphex: Innovative security label from Schreiner Medipharm in the spotlight

  • Schreiner MediPharm
Primary Packaging, Caps, Lids, Closure Components, Seals, Secondary Packaging, Labels, Tree Derivatives, Board, Board - Carton

Schreiner MediPharm’s newly developed Booklet-Label with diverse security features is especially relevant considering pending regulations such as EU 2016/161 Falsified Medicine Directive which, upon enactment in February 2019, will require innovative and reliable solutions to protect patients against falsified medicines.

The Security Booklet-Label’s bottom layer contains a tab serving as a closure seal for tampering protection. When the seal is opened, a void effect emerges as an irreversible first-opening indication.

Applied to a medicine carton, the Booklet-Label allows a pharmacist, for example, to view the product information without opening the package or destroying the tamper protection. In addition, the label is equipped with three digital security features: The BitSecure copy detection pattern, the KeySecure tracing system as well as an integrated NFC chip for smart authentication.

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Company News
  • English
  • Modified 15 Jun 2017
  • Hits 402